openPR Logo
Press release

Lupus Nephritis - Drug Pipeline Landscape, 2022 | Corestem Inc, Eledon Pharmaceuticals Inc, Equillium Bio, Hoffmann-La Roche Ltd

11-08-2022 07:26 AM CET | Health & Medicine

Press release from: Global Insight Services

Lupus Nephritis

Lupus Nephritis

Global Insight Services have recently published a report on Lupus Nephritis - Drug Pipeline Landscape, 2022. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.

Lupus Nephritis is an autoimmune kidney disease caused by systemic lupus erythematosus (SLE). It is a type of glomerulonephritis where autoantibodies affect the structures of glomeruli which results in inflammation and decreased kidney output.

Lupus Nephritis is mainly of 6 types, following minimal mesangial glomerulonephritis, mesangial proliferative glomerulonephritis, focal glomerulonephritis, diffuse proliferative nephritis, membranous glomerulonephritis and advanced sclerosing lupus nephritis.

View Detailed Report Description : https://www.globalinsightservices.com/reports/lupus-nephritis-drug-pipeline-landscape-2022/

The main cause of the lupus nephritis is the genetic predisposition, and environmental triggers interplay. The other cause is damage of the kidneys and harming their ability to filter out waste due to the immune system proteins caused by systemic lupus.

General signs and symptoms of lupus nephritis is high blood pressure, edema, malar rash, foamy urine, fatigue, joint pain, fever, blood in urine, protein in urine and impaired kidney function.

The diagnosis of lupus nephritis includes blood tests, urinalysis, X-rays, ultrasound scans of the kidneys and kidney biopsy.

The main goal in the treatment of lupus nephritis is to reduce symptoms, maintain remission, and avoiding the need for dialysis. The drug regimen includes anti-hypertensive agents, immunosuppressive agents, corticosteroids, and diuretics.

Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS31044

Report Highlights

Global Insight Service's, Lupus Nephritis - Drug Pipeline Landscape, 2022 report provides an overview of the Lupus nephritis pipeline drugs. This report covers detailed insights on Lupus Nephritis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Lupus Nephritis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Purchase your copy now : https://www.globalinsightservices.com/checkout/single_user/GIS31044

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

Key Players

Alexion Pharmaceuticals
Ampio Pharmaceuticals Inc
Asahi Kasei Pharma Corporation
AstraZeneca
BeiGene Inc
BioAegis Therapeutics Inc
Boehringer Ingelheim
ChemoCentryx Inc
Corestem Inc
Eledon Pharmaceuticals Inc
Equillium Bio
Hoffmann-La Roche Ltd
Genentech Inc

Request For Customization : https://www.globalinsightservices.com/request-customization/GIS31044

Reasons to buy Lupus Nephritis Report:

• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lupus Nephritis - Drug Pipeline Landscape, 2022 | Corestem Inc, Eledon Pharmaceuticals Inc, Equillium Bio, Hoffmann-La Roche Ltd here

News-ID: 2796417 • Views:

More Releases from Global Insight Services

Golf Tourism Market Valuation to Hit $57.3 Billion by 2034, Rising at 8.3% CAGR
Golf Tourism Market Valuation to Hit $57.3 Billion by 2034, Rising at 8.3% CAGR
Market Overview Golf Tourism Market is evolving into one of the most dynamic segments of global travel and leisure. At its core, it combines sport, luxury, and hospitality, offering golf enthusiasts the chance to play on world-class courses while enjoying premium accommodations, cultural experiences, and high-end services. This market is no longer limited to seasoned golfers-it increasingly attracts younger travelers, families, and corporate groups who view golf as part of a
Predictive Analytics Market Expected to Surpass $92.7 Billion by 2034 with 17.2% CAGR Expansion
Predictive Analytics Market Expected to Surpass $92.7 Billion by 2034 with 17.2% …
Market Overview Predictive Analytics Market is rapidly transforming industries by enabling organizations to forecast outcomes using data-driven insights. Powered by machine learning, artificial intelligence, and statistical modeling, predictive analytics helps businesses anticipate customer behaviors, mitigate risks, and optimize operations. From healthcare and retail to banking and manufacturing, industries are embracing these tools to stay competitive in a fast-changing world. As the reliance on data deepens, predictive analytics has become an essential
Sodium Lactate Market Size Projected at $5.4 Billion by 2034, Growing at 5.7% CAGR
Sodium Lactate Market Size Projected at $5.4 Billion by 2034, Growing at 5.7% CA …
Market Overview Sodium Lactate Market is gaining significant momentum as industries increasingly seek natural, multifunctional, and sustainable ingredients. Sodium lactate, a sodium salt of lactic acid, plays a crucial role across diverse applications including food preservation, pharmaceuticals, cosmetics, and industrial processes. It functions as a humectant, pH regulator, and antimicrobial agent, ensuring product safety and extending shelf life. Click to Request a Sample of this Report for Additional Market Insights: https://www.globalinsightservices.com/request-sample/?id=GIS23164 The growing
Plant Asset Management (PAM) Market to Reach $14.2 Billion by 2034, Exhibiting 6.5% CAGR Growth
Plant Asset Management (PAM) Market to Reach $14.2 Billion by 2034, Exhibiting 6 …
Market Overview Plant Asset Management (PAM) Market is becoming increasingly vital as industries push toward efficiency, sustainability, and digital transformation. PAM encompasses a wide range of technologies and strategies aimed at optimizing the lifecycle and performance of critical industrial assets. By leveraging advanced software solutions, predictive maintenance, and real-time monitoring, companies across manufacturing, energy, utilities, and oil and gas are unlocking new levels of productivity while minimizing unplanned downtime. Click to Request

All 5 Releases


More Releases for Lupus

Cutaneous Lupus Erythematosus (CLE) Market
Introduction Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma. Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C …
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market? The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and soft
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview: The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms. Market Dynamics: Drivers: Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additional
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of
Lupus Erythematosus Market -API Insights, 2017
Summary Orbis Research Present “Lupus Erythematosus-API Insights, 2017” Description The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market